Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ KIF24 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA525624
Description
KIF24 Polyclonal Antibody for Western Blot, IHC (P), Flow
Microtubule-dependent motor protein that acts as a negative regulator of ciliogenesis by mediating recruitment of CCP110 to mother centriole in cycling cells, leading to restrict nucleation of cilia at centrioles. Mediates depolymerization of microtubules of centriolar origin, possibly to suppress aberrant cilia formation. Following activation by NEK2 involved in disassembly of primary cilium during G2/M phase but does not disassemble fully formed ciliary axonemes. As cilium assembly and disassembly is proposed to coexist in a dynamic equilibrium may suppress nascent cilium assembly and, potentially, ciliar re-assembly in cells that have already disassembled their cilia ensuring the completion of cilium removal in the later stages of the cell cycle. Plays an important role in recruiting MPHOSPH9, a negative regulator of cilia formation to the distal end of mother centriole.
Specifications
KIF24 | |
Polyclonal | |
Unconjugated | |
KIF24 | |
4933425J19Rik; 9430029L23Rik; bA571F15.4; C9orf48; KIF24; kinesin family member 24; kinesin-like protein KIF24 | |
Rabbit | |
Antigen affinity chromatography, Protein A | |
RUO | |
109242, 347240 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot | |
0.5 mg/mL | |
PBS with 0.09% sodium azide; pH 7.4 | |
Q5T7B8, Q6NWW5 | |
KIF24 | |
KLH conjugated synthetic peptide between 356-384 amino acids from the N-terminal region of human KIF24. | |
400 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction